Medication Errors with Generics: Look-Alike, Sound-Alike Risks

Every year, thousands of patients in the U.S. receive the wrong medication-not because of a mistake in diagnosis, but because two drugs look or sound too much alike. This isn’t rare. It’s common. And it’s happening most often with generic drugs.

When a pharmacist reaches for a bottle labeled "hydroxyzine" but grabs "hydralazine" by accident, or when a nurse hears "atenolol" over the phone and thinks it’s "albuterol," lives are at risk. These aren’t hypotheticals. They’re documented events. The Institute for Safe Medication Practices (ISMP) tracks nearly 1,000 pairs of drugs that confuse healthcare workers. And about one in four medication errors can be traced back to this problem-known as look-alike, sound-alike (LASA) confusion.

Why Generics Are the Main Culprit

Generic drugs are essential. They make life-saving treatments affordable. But when multiple companies make the same drug, each with its own packaging, color, and shape, confusion grows. Take Valtrex and Valcyte. Both start with "val," both are used in transplant and HIV patients, and both treat viral infections. But Valtrex fights herpes, while Valcyte targets cytomegalovirus (CMV). Give a transplant patient the wrong one, and their immune system could collapse.

It’s not just brand names. Generic versions of these drugs often copy the same visual design. Pills look identical. Bottles have similar fonts and colors. Even the names are nearly interchangeable: "valacyclovir" and "valganciclovir." The only difference? A few letters. In a busy pharmacy, that’s all it takes.

How LASA Errors Happen

These errors don’t happen because someone is careless. They happen because the system is designed poorly.

Look-alike errors occur when drugs look similar. Hydroxyzine (an antihistamine) and hydralazine (a blood pressure drug) come in identical 10 mg capsules. One calms anxiety. The other lowers blood pressure. Mix them up, and a patient could crash their blood pressure-or get no relief from anxiety at all.

Sound-alike errors happen when names sound alike when spoken. Dopamine and dobutamine? Both are IV drugs used in intensive care. One boosts heart function. The other helps maintain blood pressure. Say "dopamine" over a noisy intercom, and the nurse might hear "dobutamine." The wrong drug delivered at the wrong dose can cause cardiac arrest.

According to data from the UK’s National Reporting and Learning System, over 200,000 medication incidents were reported in one year-206,485 of them involved errors, and more than 60 of those were fatal. Many of these were LASA-related.

The Human Cost

Most errors are caught before they hurt someone. But not all.

A 2022 study in the British Journal of Clinical Pharmacology found that LASA errors are responsible for roughly 25% of all preventable medication harm. In hospitals, they’re the third most common cause of adverse drug events. For children, the risk is lower in frequency-but higher in severity. A child given the wrong dose of a look-alike drug can suffer organ damage or death.

One real case from a Seattle hospital: A 72-year-old woman with heart failure was supposed to get furosemide (a diuretic). Instead, she received lorazepam (a sedative). The names look similar on paper. The bottles were stored next to each other. The nurse didn’t double-check. The patient became unresponsive. She survived, but only because the team caught it within 20 minutes.

What’s Being Done

Some hospitals are fighting back-with real results.

Tall man lettering is one of the most effective tools. It highlights differences in drug names by capitalizing the parts that differ. Instead of "prednisone" and "prednisolone," you see "predniSONE" and "predniSOLONE." This small change reduced errors by 67% in a 12-hospital system, according to a 2020 study in the Journal of Patient Safety.

Another solution? Physical separation. Keep high-risk pairs like "hydroxyzine" and "hydralazine" in completely different storage areas. No more side-by-side shelves.

Electronic health records (EHRs) now include alerts. When a doctor types "valtrex," the system pops up: "Did you mean valcyte?" Some systems even block the wrong selection entirely. A 2023 study in the Journal of the American Medical Informatics Association showed AI-powered EHRs cut LASA errors by 82% in just six months.

Barcode scanning at the bedside is another win. Nurses scan the patient’s wristband, then scan the drug. If the system detects a LASA mismatch, it stops the process. Hospitals using this method saw a 45% drop in errors.

Why It’s Still a Problem

Despite all this, LASA errors persist. Why?

First, the FDA doesn’t require generic manufacturers to match brand-name packaging. So one company’s hydroxyzine might be blue, another’s green. No standard. No consistency.

Second, many hospitals still don’t use tall man lettering. Or they use it inconsistently. A 2023 American Hospital Association survey found that Magnet-recognized hospitals (the top tier for nursing excellence) use an average of 6.2 LASA prevention strategies. Non-Magnet hospitals? Just 2.4.

Third, prescribers still write scripts by hand. A sloppy "A" looks like an "H." A rushed "D" looks like a "B." In emergency rooms, where time is tight, these mistakes slip through.

What Patients Can Do

You don’t have to wait for the system to fix itself. Here’s how to protect yourself:

• Ask your pharmacist: "Is this the same drug I’ve taken before? What’s it for?" If the pill looks different, ask why.
• Always check the label before you leave the pharmacy. Compare the name and dose to your prescription.
• If you’re on multiple drugs with similar names, ask your doctor to write out the purpose: "Hydroxyzine for anxiety" instead of just "hydroxyzine."
• Use one pharmacy. It keeps your records in one place and makes it easier to catch mistakes.

Don’t assume your provider knows. Many doctors don’t realize how many LASA pairs exist. A 2021 survey found that 40% of physicians couldn’t name even three high-risk drug pairs.

The Bigger Picture

This isn’t just about drugs. It’s about how we design care.

Dr. David Bates from Harvard Medical School says LASA errors aren’t about human error-they’re about system failure. We blame the nurse. But we don’t ask why the bottles look the same. We don’t ask why the computer lets two similar names appear side by side.

The World Health Organization calls this a global crisis. Medication errors cost the world $42 billion a year. In the U.S., 10% of hospitalized patients experience a medication error. LASA is a major part of that.

The FDA rejected 34 drug names in 2021 because they were too similar to existing ones. The European Medicines Agency now requires all new drugs to pass a name-similarity test. But in the U.S., generic manufacturers still get away with nearly identical packaging.

Change is possible. It’s just slow.

What Needs to Change

• Standardized packaging for high-risk generics. Color, shape, size-should be consistent across manufacturers.
• Mandatory tall man lettering in all EHRs and pharmacy systems.
• Real-time AI alerts during prescribing, dispensing, and administration.
• Publicly available, updated LASA lists from the ISMP, used by every hospital and pharmacy.
• Training for all healthcare workers-not just pharmacists-on LASA risks.

The goal? Reduce severe LASA errors by 50% by 2025, as the FDA’s Safe Use Initiative demands. We’ve proven it’s possible. Now we need the will.